Human Genome Project leader weighs in on Supreme Court gene patenting case

The following is an edited excerpt.

Late last year, the nation’s highest court said it would consider a legal challenge to patents that biotechnology company Myriad Genetics holds on genes linked to risk of breast cancer. Now, Eric Lander—a leader of the Human Genome Project, scientific adviser to President Obama, and head of the Broad Institute in Cambridge—has weighed in, filing an amicus brief.

The document, carefully described as Lander’s personal view, argues that Myriad has patented products of nature, which are ineligible for such protection. The patents, Lander argues, are an “insurmountable barrier” to studying the DNA, with serious repercussions for medical progress.

Read the full article here: Eric Lander, human genome project leader, weighs in on Supreme Court gene patenting case

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: The evolutionary history of the COVID-19 coronavirus

Infographic: The evolutionary history of the COVID-19 coronavirus

Reuters analysed over 185,000 genome samples from the Global Initiative on Sharing All influenza Data (GISAID), the largest database of ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend